article
Cannabinoid series: a CBD cocrystal for the treatment of PTSD
European Pharmaceutical Review spoke with Dr Andy Yates to discuss Artelo Bioscience’s new CBD and TMP cocrystal, with the potential to treat PTSD.
List view / Grid view
Formulation
whitepaper
Whitepaper: The effect of humidity on tablet surfaces containing different types of superdisintegrants
This whitepaper studies the effect of humidity on tablet surfaces containing different types of super disintegrants.
whitepaper
Whitepaper: Matrix effects on the performance of disintegrants
Superdisintegrants are categorised by their mechanism of action such as wicking, swelling or shape recovery. In this study, the performance of disintegrants from each of these groups was tested in an insoluble, hydrophobic tablet formulation.
video
Video: PROSOLV® EASYtab SP: The all-in-one product for higher productivity
Watch how PROSOLV® EASYtab, the all-in-one excipient composite, offers superior disintegration for your tablet formulations.
video
Video: JRS Pharma – The global MCC manufacturing network
Discover JRS PHARMA's industry leading manufacturing network for Microcrystalline Cellulose.
news
FDA proposes four APIs for bulk substances list for outsourcing facilities
Four APIs are being considered by the FDA for its bulk drug substances list for potential use by outsourcing facilities when compounding if there is a clinical need.
news
EC approves subcutaneous formulation of Remsima®
The European Commission has granted marketing authorisation to Celltrion's Remsima (infliximab, CT-P13) subcutaneous formulation.
news
Study suggests some excipients in common drugs are biologically active
Preliminary research has revealed that some excipients used in common medications may interact with important human enzymes and receptors.
whitepaper
Whitepaper: Effective and fast approval of incident investigation reports
This whitepaper from NSF explains how to conduct an efficient and effective review and approval of incident reports.
news
Inhaled interferon beta therapy shows promise in COVID-19 trial
SNG001 diminished the risk of COVID-19 patients developing severe symptoms, reduced breathlessness and improved recovery rates.
news
Inhaled formulation of remdesivir enters clinical trials
Gilead reveals the novel inhaled formulation of remdesivir entered Phase I trials to establish if it could be used to treat mild to moderate COVID-19.
news
Long-acting injectable HIV PrEP outperforms commercially available daily pill
Extensive analysis of interim data finds patients given cabotegravir injection had a 66 percent lower incidence of HIV acquisition than those taking Truvada pills.
article
Expert view: Investigating drug carriers and in vitro models with advanced analytical imaging techniques
Dr Maike Windbergs discusses the use of Raman imaging in pharmaceutical research and the potential of combining different analytical techniques.
news
Inhaled formulation of remdesivir to be tested as COVID-19 treatment
Gilead Sciences has said it will initiate clinical trials in August to test an inhaled formulation of remdesivir, a potential COVID-19 therapy.
article
Formulation, Development & Delivery In-Depth Focus 2020
The articles in this in-depth focus outline the advantages of repurposing existing drugs for new indications and reveal why implantable systems and microparticle depots as drug delivery systems can aid patient compliance.
